The answer to that question, at present, is that we don’t know — but it’s probably very few indeed compared to all the men who have progressive forms of prostate cancer. … READ MORE …
Filed under: Diagnosis, Drugs in development, Management, Risk, Treatment | Tagged: genome, informed, oncology, precision, targeted | 1 Comment »
A relatively brief, current, full-text review article by Loeb and Ross is available on the Medscape web site and discusses the three currently available tests for assessment of genomic risk for men with localized forms of prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: Decipher, genome, Oncotype, prognosis, PROLARIS, test | 6 Comments »
Regular readers of the medical science literature will be very conscious of the emphasis on genomic analysis of tumor specimens as a way to try to “personalize” treatment of cancers of many types — prostate cancer very specifically included. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: DNA, genome, individualized, medicine, personalized, sequencing, Treatment | 10 Comments »
Researchers at a consortium of seven major cancer centers have been awarded a $10 million, 3-year grant to continue explorations into the individualization of treatment for men with advanced and metastatic forms of prostate cancer. The grant is funded in a collaboration between Stand Up To Cancer (SU2C) and the Prostate Cancer Foundation (PCF). … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: CRPC, genome, grant, individualized, reserach | Leave a comment »
We know from a number of older, epidemiologic studies that there seems to be an inverse association between diabetes status and prostate cancer risk. In other words, people with diabetes seem to be less likely to be diagnosed with prostate cancer. … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: allele, diabetes, genetics, genome, risk | Leave a comment »
Under the “And this helps me how?” column we can now add the topic of a possible genetic link between endometrial cancer and prostate cancer (maybe). … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: cancer, endometrial, genome, SNP, womb | Leave a comment »
There has been little doubt over the years that prostate cancer was a genetically complex disease. No one has ever seriously thought that prostate cancer was the result of a single change in the DNA of the individual patient. Now we finally have some proof! … READ MORE …
Filed under: Diagnosis, Management, Prevention, Risk | Tagged: Diagnosis, genome, prognosis, risk | 3 Comments »
A large study of genetic markers in Japanese prostate cancer patients has clearly shown that some of the markers of prostate cancer in Caucasians do not appear in Japanese patients whereas new markers appear to be common among Japanese. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: association, genetics, genome, SNP | Leave a comment »
Today’s news reports deal with such items as:
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: brachytherapy, Diagnosis, genome, MRI, MRSI, prognosis, quality of life, salvage, SNPs | 2 Comments »
In today’s news report we touch on papers that address:
Filed under: Living with Prostate Cancer, Management, Prevention, Risk, Treatment | Tagged: 5α-reductase inhibitor, focal therapy, genome, marker, Prevention, risk, selenium, SNP, targeted | Leave a comment »
The New York Times has started a series of science articles for its readers on “the frontiers of biology,” which may be helpful and entertaining for at least some readers of this blog. The first article, by Nick Wade, addresses what a genome is and how it actually works.
However, there seems to be no new article from Dana Jennings this week. We hope he’s just taking a brief break to recharge the engines.
Filed under: Uncategorized | Tagged: genome | Comments Off on Some continuing biology education anyone?
THE "NEW" PROSTATE CANCER INFOLINK 